UC BRAID Center for Accelerated Innovation

UC BRAID 加速创新中心

基本信息

批准号：
9126594
负责人：
MICHAEL J PALAZZOLO
金额：
$ 252.88万
依托单位：
UNIVERSITY OF CALIFORNIA LOS ANGELES
依托单位国家：
美国
项目类别：
财政年份：
2013
资助国家：
美国
起止时间：
2013-09-26 至 2020-07-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/9126594
关键词：
Acceleration Accounting Address Adopted Affect American Asthma Atrial Fibrillation Award Biological Markers Biomedical Engineering Biomedical Research Biopolymers Blood Pressure Businesses California Capital Cardiac Cardiac ablation Cardiovascular Diseases Cardiovascular Physiology Cardiovascular system Cause of Death Cells Cerebrovascular Disorders Clinical Clinical Research Clinical Sciences Clinical and Translational Science Awards Collaborations Communities Congestive Heart Failure Creativeness Development Devices Diagnostic Diagnostic tests Disclosure Ecosystem Engineering Ensure Faculty Funding Goals Grant Hamman-Rich syndrome Health Health Sciences Heart Diseases Hematological Disease Hydrogels Implant Incubated Industrial Product Industry Intellectual Property Investments Joints Knowledge Laboratories Legal Legal patent Licensing Link Los Angeles Lung diseases Mechanics Medical Medical Device Mentors Mentorship Methods Microscopy Mission Modeling National Heart, Lung, and Blood Institute Nonprofit Organizations Organizational Innovation Outcome Pathology Patient Care Patients Pharmaceutical Preparations Positioning Attribute Primates Process Productivity Pulmonary veins Research Research Infrastructure Research Institute Research Personnel Resources Retrieval San Francisco Skills Development Staging Structure System Technology Technology Transfer Testing Therapeutic Tissue Microarray Tissues Training and Education Transfusion Translating Translational Research Translations United States Food and Drug Administration United States National Institutes of Health Universities Ventricular Work base blood product commercialization design experience fighting hemodynamics improved innovation invention medical schools meetings multidisciplinary product development programs reconstruction skill acquisition small molecule success technology development tissue repair volunteer

项目摘要

The University of California Center for Accelerated Innovation proposes to create new mechanisms and to leverage its diverse strengths in diagnostics, therapeutics, and devices to support translation of promising early-stage inventions for patient benefit. The Center is a consortium of the five UC medical campuses: UC Davis, UC Irvine, UC Los Angeles, UC San Diego, and UC San Francisco. Each campus has a thriving research enterprise, nationally ranked medical school, and translational research institute funded by Clinical and Translational Science Awards (CTSA). Together, our five campuses account for nearly 7% of NHLBI's grant funding. The Center taps into the vigor and creativity of California's legendary biomedical and engineering ecosystem and integrates the many successful business, engineering and health sciences programs at our campuses. Our program will partner with well-established biomedical companies, venture capital firms, industry organizations and nonprofits focused on medical innovation. The Center is supported by UC Biomedical Research Acceleration, Integration, and Development (UC BRAID), a joint effort of the five UC biomedical campuses designed to catalyze and accelerate biomedical, clinical, and translational research across the UC system. Together we will: 1) Engage University of California heart, lung and blood disease innovators in entrepreneurism through a comprehensive education, training and mentorship program. 2) Solicit and select technologies with high commercial potential that align with NHLBI's mission and address unmet medical needs or significant scientific opportunity. 3) Incubate our most promising technologies in accordance with industry requirements to facilitate their translation to commercial products that improve patient care and enhance health. 4) Create a high-performing, sustainable infrastructure that will serve as a model to academic research centers. These programs will create an integrated, sustainable infrastructure to accelerate the translation of our NHLBI-funded discoveries to the marketplace in order to promote health and improve patient care.

加利福尼亚大学加速创新中心提议创建新机制，并利用其在诊断，治疗学和设备方面的多种优势来支持有前途的翻译早期发明以供患者利益。该中心是五个UC医疗校园的财团：UC 戴维斯，加州大学欧文分校，加州大学洛杉矶分校，加州大学圣地亚哥分校和加州大学旧金山加州大学。每个校园都有一个繁荣的研究企业，全国排名的医学院和翻译研究所由临床资助和翻译科学奖（CTSA）。我们的五个校园在一起占NHLBI的近7％赠款。该中心攻入加利福尼亚传奇生物医学和工程生态系统的活力和创造力并在我们的校园中整合了许多成功的商业，工程和健康科学计划。我们的计划将与成熟的生物医学公司，风险投资公司，行业合作组织和非营利组织的重点是医疗创新。该中心由UC生物医学支持研究加速，整合和开发（UC编织），这是五个UC生物医学的共同努力旨在催化和加速UC的生物医学，临床和转化研究的校园系统。我们将共同：1）与加利福尼亚大学心脏，肺和血液疾病创新者互动通过全面的教育，培训和指导计划，企业家精神。 2）征求并选择与NHLBI的使命相吻合的具有很高商业潜力的技术，并解决未满足的医学需求或巨大的科学机会。 3）根据行业要求，以促进其转化为改善患者护理和的商业产品增强健康。 4）创建一个高性能，可持续的基础设施，将作为模型学术研究中心。这些计划将创建一个集成，可持续的基础设施，以加速我们的翻译 NHLBI资助了市场的发现，以促进健康并改善患者护理。